Monopar Therapeutics
MNPR
$0.60
Share price
-9.38%
Change (1 day)
-30.45%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) - Cash on Hand
Cash on Hand as of December 2023 : $7.26 M
According to Monopar Therapeutics's latest financial reports the company has $7.26 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Monopar Therapeutics - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $13.11 M | -35.38% |
| 2021-12-31 | $20.3 M | 21.31% |
| 2020-12-31 | $16.73 M | 26.66% |
| 2019-12-31 | $13.21 M | 91.71% |
| 2018-12-31 | $6.89 M | -23.26% |
| 2017-12-31 | $8.98 M | 333.36% |
| 2016-12-31 | $2.07 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 2,765.19% | 🇺🇸 USA |